688639.SH
华恒生物
SSE · Healthcare · Biotechnology · CN
CNY 16.08
−3.65%Forward multiples
Based on analyst estimates
- P/E forward
- 23.55x
- P/E 2026E
- 18.25x
- P/E 2027E
- 16.16x
- P/E 2028E
- 14.10x
- P/S forward
- 2.49x
Trailing multiples
Trailing twelve months
- P/E TTM
- 30.37x
- PEG TTM
- 0.69x
- Price / book
- 1.52x
- Price / sales
- 1.50x
- Price / cash flow
- 43.45x
Enterprise value
- Enterprise value
- CNY 5.9B
- EV / sales
- 2.01x
- EV / EBITDA
- 16.85x
- EV / EBIT
- 52.34x
- Market cap
- CNY 4.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026